The medical-grade cannabis producer is looking to maximize opportunities for product expansion in the Canadian market
Inc () (OTCMKTS:FSDDF) announced it had signed an agreement to explore insurance coverage for medical cannabis throughout Canada.
The licensed producer of pharmaceutical-grade cannabis is contracting the services of Joseph L. Romano, a lawyer with a strong track record in personal injury law.
Romano has been working for nearly 13 years to assist people coping with chronic pain to have access to medical cannabis.
READ: Cannabis company FSD Pharma subsidiary FV Pharma names Sara May as president
As part of the consulting agreement, Romano will add strategic insight on the inner workings of third-party actions, WSIB claim handling, first-party coverage and no-fault benefits across Canada. Additionally, he will assist in identifying strategic acquisitions for .
“We are very excited to engage Mr. Romano in advance of our anticipated sales license,” said Dr. Raza Bokhari, executive co-chairman and interim CEO at FSD Pharma. “This is a very timely and important agreement for FSD Pharma to maximize the opportunities in the Canadian market for our products and fits well with our strategy of establishing the company as a leader in medical cannabis.”
FSD Pharma grows medical-grade cannabis at its 25,000 square foot facility in Ontario, with an additional 220,000 expected to be added by the end of 2019.
Shares of FSD Pharma were trading at C$0.23 in Canada and US$0.17 in the US before market open on Thursday.
Contact Angela at [email protected]
Follow her on @AHarmantas